SLDB Latest Press Releases

-- September 2, 2026 --

Solid Biosciences to Participate at Upcoming Investor Conferences Globe Newswire 8:00 AM

-- August 6, 2026 --

Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates Globe Newswire 4:08 PM

-- June 1, 2026 --

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

Solid Biosciences to Participate at Upcoming Investor Conferences Globe Newswire 8:00 AM

-- May 12, 2026 --

Solid Biosciences Reports First Quarter 2026 Financial Results and Provides Business Updates Globe Newswire 4:08 PM

-- May 7, 2026 --

Solid Biosciences Doses First Participant in Phase 3 IMPACT DUCHENNE Clinical Trial Evaluating SGT-003 in Duchenne Muscular Dystrophy Globe Newswire 8:00 AM

-- May 1, 2026 --

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- April 30, 2026 --

Solid Biosciences to Showcase a Large Presence at the 29th Annual Meeting of the American Society of Gene and Cell Therapy Globe Newswire 8:00 AM

-- April 28, 2026 --

Solid Biosciences Announces Receipt of European Commission Orphan Drug Designation for SGT-003 for the Treatment of Duchenne Muscular Dystrophy Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software